Диагностика, особенности периоперационного ведения и отдаленные результаты стентирования коронарных артерий у больных ИБС с сахарным диабетом 2 типа
Диссертация
Наблюдательные исследования, охватившие большое число пациентов, подтверждают, что коронарная ангиопластика демонстрирует высокую эффективность и низкую частоту осложнений (Smith S.C., 2001) по сравнению с другими методами реваскуляризации миокарда. Тем не менее, при выборе 4KB остается еще много открытых вопросов, качественное решение которых во многом зависит от понимания гетерогенности причин… Читать ещё >
Список литературы
- Балаболкин М.И. Диабетология . М.: Медицина, 2002.
- Балаболкин М.И., Клебанова Е. М. Роль окислительного стресса в патогенезе сосудистых осложнений диабета (лекция). Проблемы эндокринологии. 2000−6:29−34.
- Бокерия Л.А., Алекян Б. Г. Рентгенэндоваскулярная диагностика и лечение заболеваний сердца и сосудов в Российской Федерации 2007 год. М.: НЦССХ им. А. Н. Бакулева, 2009.
- Бондарь И.А., Климентов В. В., Поршенников И. А. Оксид азота и диабетические ангиопатии. Сахарный диабет. 1999−4:11−14.
- Будылина С.М., Давыдов А. Л. Физиология человека. -1993-Т. 19:121−126.
- Вербовая Н.И., Лебедева Е. А. Роль гликозилированных продуктов метаболизма в формировании сосудистых осложнений сахарного диабета. Проблемы эндокринологии. 1997−1:43−46.
- Дедов И. И., Шестакова М. В., Максимова М. А. Федеральная целевая программа «Сахарный диабет». Методические рекомендации. Москва 2002 г.
- Дубошина Т.Б. Оптимизация методов лечения хирургических больных с соптствующим СД (с учётом эндокринных реакций). Автореферат кандитатской диссертации. Саратов, 1998.
- Кулешов Е.В., Кулешов С. Е. Сахарный диабет и хирургические заболевания. -М: Воскресенье, 1996.
- Ройтберг Г. Е. Метаболический синдром. М.: МЕДпресс-информ 2007- 13−83
- Соколов Е.И. Диабетическое сердце. М.: Медицина, 2002
- Соледад С.М., Карр Д. Б. Нейроэндокринные реакции на послеоперационную боль. М.: Медицина, 1998.
- Сорокин Е. В., Карпов Ю. А. Статины, эндотелий и сердечнососудистый риск. РМЖ. Реферат 2001. http://www.nTij.ru.
- Хартинг B.C. Современная инфузионная терапия и парентеральное питание-М, 1982-С.250
- Чеботарева Г. Е. Оптимизация дооперационной подготовки и периоперационного ведения больных ИБС, страдающих сахарным диабетом 2 типа. Автореферат кандитатской диссертации. Москва, 2005
- Abaci A, Oguzhan A, Kahraman S, et al. Effect of diabetes mellitus on formation of coronary collateral vessels. Circulation. 1999−99:2239−2242.
- Abdella N, Mosimineyi O, Moussa M. Case control study of C-reactive protein with coronary heart disease in patients with type 2 diabetes mellitus. Diabetes. 2002−51(suppl 2): 1165−1166.
- American Diabetes Association. Standards of medical care in diabetes-2008 //Diabetes Care. 2008−31(Suppl. l):12−54.
- Anderson HV, Shaw RE, Brindis RG, et al. A contemporary overview of percutaneous coronary interventions: the American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR). JACC. 2002−39:1096 -103.
- Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ. 2002- 324:71−86.
- Avendano G.F., Agarwal R.K., Bashey R.I. et al. Effect glucose intolerance on myocardial function and collagen-linked glycation. Diabetes. 1999−48:1443
- Balkou B., Shipley M., Jarrett R. J. et al. High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic me. Diabetes Care. 1998−21:360−367.
- Barrett Connor E. M. Does hyperglycemia really cause coronary heart disease? Diabetes Care. 1997−20:1620−1623.
- Bartholomew BA, Harjai KJ, Dukkipati S, et al. Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification. Am J Cardiol 2004−93:1515−9.
- Benjamin EJ, Levy D, Vaziri SM et al. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA. 1994−271:840−844.
- Berg TJ, Snorgaard O., Faber J. et al. Serum level o advanced end product are associated with left ventricular diastolic dysfunction in patient with type 1 diabetes. Diabetes Care. 1999−22:1186
- Bhatt DL, Marso SP, Lincoff M, et al. Abciximab reduces mortality in diabetics following percutaneous coronary intervention. JACC. 2000−35: 922−928.
- Bojar R.M. Manual of perioperative care in adult cardiac surgery. Fourth edition. Blackwell Pubishing: 2005.
- Breuer HW. Characteristics of atherosclerotic plaque in diabetics. Herz. 2002−27(2): 189−92.
- Breuer HWM. The postprandial blood glucose level A new target for optimizing treatment of diabetes mellitus. EHJ Supplements. 2000- Vol 2, Iss D, pp D36-D38.
- Budde T, Haude M, Hopp HW, et al. A prognostic computer model to individually predict post-procedural complications in interventional cardiology: the INTERVENT Project. EHJ. 1999−20:354−63.
- Budde T, Haude M, Hopp HW, et al. A prognostic computer model to individually predict post-procedural complications in interventional cardiology: the INTERVENT Project. EHJ. 1999−20:354−63.
- Burchfiel CM, Reed DM, Marcus EB, Strong JP, Hayashi T. Association of diabetes mellitus with coronary atherosclerosis and myocardial lesions: an autopsy study from the Honolulu Heart Program. Am J Epidemiol. 1993−137:1328−1340.
- Bypass Angioplasy Revascularization Investigation (BARI) Investigators. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. NEJM. 1996−335:217−225.
- Bypass Angioplasy Revascularization Investigation (BARI) Investigators. Seven-year outcome in the Bypass Angioplasty Revascularization Investigation (BARI) by treatment and diabetic status. JACC. 2000−35:1122−1129.
- Carrozza JP Jr., Kuntz RE, Fishman RF, Baim DS. Restenosis after arterial injury caused by coronary stenting in patients with diabetes mellitus. Ann Intern Med. 1993−118:344−9.
- Celermajer D.S. Endothelial dysfunction: does it matter? Is it reversible? JACC. 1997−30:325−333
- Ceriello A, Quagliaro L, D’Amico M, et al., Acute hyperglycemia induces nitrotyrosine formation and apoptosis in perfused heart from rat. Diabetes 2002−51:1076−1082
- Chaudhuri A., Janicke D., Wilson M. F. et al. Anti-Inflammatory and Profibrinolytic Effect of Insulin in Acute ST-Segment-Elevation Myocardial Infarction. Circulation 2004−109−849−854
- Chen-Scarabelli C. and Scarabelli T.M. Suboptimal Glycemic Control, Independently of QT Interval Duration, Is Associated with Increased Risk of Ventricular Arrhythmias in a High-Risk Population. PACE. 2006−29:9−14
- Chew DP, Bhatt DL, Robbins MA, et al. Incremental prognostic value of elevated baseline C-reactive protein among established markers of risk in percutaneous coronary intervention. Circulation. 2001−104:992−7.
- Cinar Y, Senyol A, Duman K: Blood viscosity and blood pressure: role of temperature and hyperglycemia. American J Hypertens 2001−14:433−438
- Cohen O, Dankner R, Chetrit A et al. Multidisciplinary intervention for control of diabetes in patients undergoing coronary artery bypass graft. Cardiovasc Surg. 2003- 11(3): 195−200.
- Collins R, Armitage J, Parish S, Sleigh P, Peto R- HPS Collaborative Group. MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatinin 5,963 people with diabetes: a randomized placebocontrolled trial. Lancet. 2003−361:2005−2016.
- Collins R, Armitage J, Parish S, Sleight P, Peto R. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002−360:7−22.
- Corpus RA, George PB, House JA, et al. Optimal glycemic control is associated with a lower rate of target vessel revascularization in treated type II diabetic patients undergoing elective percutaneous coronary intervention. JACC. 2004−43:8−14.
- Creager MA, Luscher TF, Cosentino F, Beckman JA. Diabetes and vascular disease pathophysiology, clinical consequences, and medical therapy: part I. Circulation. 2003−108:1527−1532.
- Dale A.C., Midthjell K.M., Nilsen T.I. et al. Glycemic control in diabetes and mortality from IHD: twenty years follow-up og the HUNT-1 study in Norway. EHJ 2008−29:abstract supplement, p.139.
- Dandona P, Aljada A, Mohanty P, et al. Insulin inhibits intranuclear nuclear factor kB and stimulates kB in mononuclear cells in obese subjects: evidence for an anti-inflammatory effect. J Clin Endocrinol Metab. 2001−86:3257−3265.
- Dandona P., Chaudhuri A., Ghanim H., Mohanty P. Insulin as an Anti-Inflammatory and Antiatherogenic Modulator JACC, 2009−53:14−20
- Davi G, Catalan I, Averna M. Thromboxane biosynthesis and platelet function in type II diabetes mellitus. NEJM. 1990−322:1769−1774.
- Dimitriadis E., Griffin M. A study of lesions of the intramural coronary artery branches in diabetes mellitus. Diabetologia. 1995−39:97 102.
- Dukkipati S., O’Neill W.W., Harjai K.J. et al. Characteristics of Cerebrovascular Accidents After Percutaneous Coronary Interventions JACC. 2004−43−1161−1167
- Engler R, Yellon D: Sulfonylurea K-ATP blockade in type II diabets and preconditioning in cardiovascular disease: time for reconsideration. Circulation. 1996−94:2297−2301
- Farkouh ME, Dangas G, Leon MB et al. Design of the Future
- REvascularization Evaluation in patients with Diabetes mellitus: Optimal172management of Multivessel disease (FREEDOM) Trial. Am Heart J. 2008- 155(2):215−23
- Flaherty James D., Davidson Charles J.- Diabetes and Coronary Revascularization. JAMA. 2005−293:1501−1508
- Fontbonne AM, Eschwege EM. Insulin and cardiovascular disease. Paris Prospective Study. Diabetes Care. 1991−14(6):461−469.
- Forsen A, Kangro M, Sterner G et al. A 14-year prospective study of autonomic nerve function in Type 1 diabetic patients: association with nephropathy. Diabet Med. 2004−21:852−858.
- Fournier AM, Gadia MT, Kubrusly DB, Skyler JS, Sosenko JM. Blood pressure, insulin, and glycemia in nondiabetic subjects. Am J Med 1986- 80: 861−864.
- Fox CS, Sullivan L, D’Agostino RB Sr, Wilson PW, for the Framingham Heart Study. The significant effect of diabetes duration on coronary heart disease mortality: the Framingham Heart Study. Diabetes Care. 2004−27: 704−708.
- Franco OH, Steyerberg EW, Hu FB, Mackenbach J, Nusselder W. Associations of diabetes mellitus with total life expectancy and life expectancy with and without cardiovascular disease. Arch Intern Med. 2007- 167: 1145−1151.
- Fuchs Sh., Stabile Eu., Kinnaird T.D. et al. Stroke Complicating Percutaneous Coronary Interventions Incidence, Predictors, and Prognostic Implications. Circulation 2002−106:86−91
- Furnary AP, Gao G, Grunkemeier GL, et al. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2003−125:1007−1021.
- Gaede P., Lund-Anderson H., Parving H. Et al. Effect of a multifactorial intervention on mortality in type 2 diabates. NEJM 2008−358:580−591
- Gandhi G.Y., Nuttall' G.A., Abel M.D. et al. Intraoperative hyperglycemia and perioperative outcomes in cardiac surgery patients. Mayo Clin Proc.2005−80:862−6.
- Ghosh S., Standen N.B., Galinianens M. Failure to precondition pathological human myocardium. JACC 2001−37:711
- Ginsberg H.N., Bonds D.E., Lovato L.C. et al. ACCORD Study Group. Evolution of the Lipid Trial Protocol of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial // Amer. J. Cardiology. 2007- 99(Suppl. A):56−67.
- Goraya TY, Leibson CL, Palumbo PJ, et al. Coronary atherosclerosis in diabetes mellitus: a populationbased autopsy study. JAmColl Cardiol. 2002−40:946−953.
- Gordon French. Clinical Management of Diabetes Mellitus During Anaesthesia and Surgery. Practical procedures. Issue 11, 2000
- Guerci B, Bohme P, Kearney-Schwartz A, et al. Endothelial dysfunction and type 2 diabetes. Diabetes Metab. 2001−27:436−447.
- Haffner S.M. Clinical relevance of the oxidative stressconcepty. Metabolism. 2000−49(Suppl l):30−34.
- Haffher SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M: Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. NEJM 1998−29−234
- Hamano K., Kawamura T., Gohra H. Stress Caused by Minimally Invasive Cardiac Surgery versus Conventional Cardiac Surgery: Incidence of Systemic Inflammatory Response Syndrome. World Journal of Surgery 2001−25:117−121
- Hammoud T, Tanguay JF, Bourassa MG. Management of coronary artery disease: therapeutic options in patients with diabetes. JACC 2000−36:355−65.
- Hanefeld M, Temelkova-Kurtschiev T. The postprandial state and the risk of atherosclerosis. Diabet Med. 1997- 14: S6−11
- Hanley AJG, Williams K, Stern MP, Haffiier SM. Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease: the San Antonio Heart Study. Diabetes Care 2002−25:1177- 84.
- Harrell L, Schunkert H, Palacios IF. Risk predictors in patients scheduled for percutaneous coronary revascularization. Catheter Cardiovasc Interv 1999−48:253−60.
- Heart Outcomes Prevention Evaluation Study Investigators. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Lancet. 2000−355:253−259.
- Henderson RA, Pocock SJ, Sharp SJ, et al- Randomised Intervention Treatment of Angina. Longterm results of RITA-1 trial: clinical and cost comparisons of coronary angioplasty and coronary-artery bypass grafting. Lancet. 1998−352:1419−1425.
- Hensley F.A., Eugene Martin D., Gravlee G.P. A practical approach to cardiac anesthesia. 4th edition. Lippincott Williams & Wilkins. 2007
- Hermiller JB, Tenaglia AN, Kisslo KB, et al. In vivo validation of compensatory enlargement of atherosclerotic coronary arteries .AmJ Cardiol. 1993−71:665−668.
- Hong S. J., Kim M.H., Ahn Y.K. et al. Multiple predictors of coronary restenosis after drug-eluting stent implantation in patients with diabetes. Heart 2006−92−1119−1124
- Hotamisligil GS, Arner P, Caro JF. Increased adipose tissue expression of tumor necrosis factor in human obesity and insulin resistance. J Clin Invest. 1995−95:2409−2415.
- Hotamisligil, G. S., Spiegelman, B. M. Tumor necrosis factor alpha: a key component of the obesity-diabetes link. Diabetes 1994−43, 1271−1278 .
- Hyun S. Cho, Jeong J. Lee, Ik S. Chung et al. Insulin Reverses Bupivacaine-Induced Cardiac Depression in Dogs. Anesth. Analg. 2000- 91:10 961 102.
- Iakovou I, Schmidt T, Bonizzoni E, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005−293:2126−30.
- Jonas M, Reicher-Reiss H, Boyko V, et al- Bezafibrate Infarction Prevention (BIP) Study Group. Usefulness of beta-blocker therapy in patients with noninsulin- dependent diabetes mellitus and coronary artery disease. Am J Cardiol. 1996−77:1273−1277.
- Jouven X, Lemaitre RN, Rea TD et al. Diabetes, glucose level, and risk of sudden cardiac death. EHJ 2005−26:2142−2147.
- Kahn BB, Flier JS. Obesity and insulin resistance. J Clin Invest 2000−106:473−81.
- Keech A, Simes RJ, Barter P, et al. Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial. Lancet 2005−366:1849−61.
- Kersten J, Schmeling T, Orth K, Pagel P, Warltier D: Acute hyperglycemia abolishes ischemic preconditioning in vivo. Am J Physiol 275: H721-H725,1998
- King SB, Kosinski AS, Guyton RA, Lembo NJ, Weintraub WS- EAST Investigators. Eight-year mortality in the Emory Angioplasty versus Surgery Trial (EAST). J Am Coll Cardiol. 2000−35:1116−1121.
- King H., Aubert RE., Herman WH. Global burden of diabetes, 1995 — 2025: prevalence, numerical estimates, and projections. Diabetes Care. 998−21:1414−1431.
- Klein R. Hyperglycemia and microvascular and macrovascular disease in diabetes. Diabetes Care. 1995−18:258 268.
- Kornowski R, Mintz GS, Kent KM, et al. Increased restenosis in diabetes mellitus after coronary interventions is due to exaggerated intimal hyperplasia: a serial intravascular ultrasound study. Circulation 1997−95:1366−9.
- Krahn AD, Manfreda J, Tate RB et al. The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. Am J Med 1995−98:476−484.
- Lazar HL, Chipkin SR, Fitzgerald CA, Bao Y, Cabral H, Apstein CS. Tight glycemic control in diabetic coronary artery bypass graft patients improves perioperative outcomes and decreases recurrent ischemic events. Circulation. 2004−109:1497−1502.
- Ledru F, Ducimetiere P, Battaglia S, et al. New diagnostic criteria for diabetes and coronary artery disease: insights from an angiographic study. JACC. 2001−37:1543−1550.
- Legrand VM, Serruys PW, Unger F, et al. Threeyear outcome after coronary stenting versus bypass surgery for the treatment of multivessel disease. Circulation. 2004- 109:1114−1120.
- Lemp GF, Vander Zwaag R, Hughes JP, et al. Association between the severity of diabetes mellitus and coronary arterial atherosclerosis. Am J Cardiol. 1987- 60:1015−1019.
- Levy S, Maarek M, Coumel P et al. Characterization of different subsets of atrial fibrillation in general practice in France: the ALFA study. The College of French Cardiologists. Circulation 1999−99:3028−3035.
- Macaya C, Garcia H, Serruys PW, et al. Sirolimus-eluting stent versus surgery and bare metal stenting in the treatment of diabetic patients with multivessel disease—a comparison between ARTS II and ARTS I. Circulation 2005−112(suppl II):II-655.
- Mak KH, Faxon DP. Clinical studies on coronary revascularization in patients with type 2 diabetes. EHJ. 2003−24:1087−1103.
- Mak KH, Moliterno DJ, Granger CB, et al- GUSTO-I Investigators. Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction. JACC. 1997−30:171−179.
- Marfella R, Esposito K, Gionta R, et al. Circulating adhesion molecules in humans: role of hyperglycemia and hyperinsulinemia. Circulation. 2000−101:2247−2251.
- Marfella R, Nappo F, Angelis LD, et al. Hemodynamic effects of acute hyperglycemia in type 2 diabetic patients. Diabetes Care 23:658−663, 2000
- Marfella R, Nappo F, Angelis LD, Siniscalshi M, et al. The effect of acute hyperglycaemia on QTc duration in healthy man. Diabetologia 43:571−575, 2000
- Marfella R., Di Filippo C., Portoghese M. et al. Tight Glycemic Control Reduces Heart Inflammation and Remodeling During Acute Myocardial Infarction in Hyperglycemic Patients. JACC 2009−53:1425−36
- Mazeika P, Prasad N, Bui S, Seidelin PH. Predictors of angiographic restenosis after coronary intervention in patients with diabetes mellitus. Am Heart J 2003−145:1013−21.
- McDonagh P.F., Hokama J.Y. Microvascular perfusion and transport in the diabetic heart. Microcirculation. 2000−7:163
- Moghissi E.S., Korytkowski M.T., Dinardo M. et al. American Association of Clinical Endocrinologists and American Diabetes Association
- Consensus Statement on Inpatient Glycemic Control Diabetes Care 2009−32 (6): 1119−1131
- Moreno PR, Murcia AM, Palacios IF, et al. Coronary composition and macrophage’infiltration in atherectomy specimens from patients with diabetes mellitus. Circulation. 2000−102:2180−2184.
- Mori Brooks M., Alderman E.L., Bates E. et al. The Final 10-Year Follow-Up Results From the BARI Randomized Trial. JACC 2007−49- 1600−1606
- Moses JW, Leon MB, Popma JJ, et al- SIRIUS Investigators. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. NEJM. 2003−349:1315−1323.
- Nesto RW. Correlation between cardiovascular disease and diabetes mellitus: current concepts. AmJMed.2004−116(suppl 5A):11S-22S.
- Oliver M.F. et al. Effect of glucose and fattu acids on myocardial ischemia and arrhythmias. Lancet 343- 155, 1994
- Surgery, American Heart Association, and the American Society of Nuclear Cardiology Endorsed by the American Society of Echocardiography, the Heart Failure Society of America, and the Society of Cardiovascular Computed Tomography. JACC. 2009−53−530−553
- Pepys M.B., Hirschfield G.M., Tennent G.A. et al. Targeting C-reactive protein for the treatment of cardiovascular disease Nature 2005- 440, 1217−1221
- Pitkanen O.P., Nuutila P., Paitakari O.T. et al. Coronary flow reservetin younf man with IDDM. Diabetes. 1999−99:2239
- Ricciardi MJ, Davidson CJ, Gubernikoff G, et al. Troponin I elevation and cardiac events after percutaneous coronary intervention. Am Heart J 2003−145:522−8
- Rihal CS, Textor SC, Grill DE, et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 2002−105:2259−64.
- Rotter V, Nagaev I, Smith U. Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects. J Biol Chem 278: 45 777−45 784, 2003.
- Rozanski GJ, Xu Z. A metabolic mechanism for cardiac K+ channel remodelling. Clin Exp Pharmacol Physiol 2002−29:132−137.
- Satu Vehkavaara- Sari Makimattila- Anna Schlenzka- Juha Vakkilainen- Jukka Westerbacka- Hannele Yki-Jarvinen Insulin Therapy Improves Endothelial Function in Type 2 Diabetes Arteriosclerosis, Thrombosis, and Vascular Biology. 2000−20:545
- Scherpereel P. Perioperative care of diabetic patient. Minerva Anestesiol. 2001- 67(4): 258−62.
- Schroeder EB, Chambless LE, Liao D et al. Atherosclerosis Risk in Communities (ARIC) Study. Diabetes, glucose, insulin, and heart rate variability: the Atherosclerosis Risk in Communities (ARIC) Study. Diabetes Care 2005−28:668−674.
- Shamir R, Shehadeh N, Rosenblat M, et al. Oral insulin supplementation attenuates atherosclerosis progression in apolipoprotein E-deficient mice. Arterioscler Thromb Vase Biol 2003−23:104 -10.
- Shepherd J, Blauw GJ, Murphy MB, et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet 2002−360:1623−30.
- Singh JP, Larson MG, O’Donnell CJ et al. Association of hyperglycemia with reduced heart rate variability (The Framingham Heart Study). Am J Cardiol 2000−86:309−312.
- Singh M, Lennon RJ, Holmes DR, Jr., Bell MR, Rihal CS. Correlates of procedural complications and a simple integer risk score for percutaneous coronary intervention. JACC 2002−40:387−93.
- Sinzinger H. Feigl W.Silberbauer K. Prostacyclin generation in atherosclerotic arteries. Lancet 1981- 2: 100−102.
- Skyler J.S., Bergenstal R., Bonow R.O. Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials. JACC 2009−53−298−304
- Smith SC, Faxon D, Cascio W, et al. Diabetes and cardiovascular disease writing group VI: revascularization in diabetic patients. Circulation. 2002−105:el65-el69.
- Sowers JR. Obesity as a cardiovascular risk factor. Am J Med 2003−115:37−41.
- Stanley WC, Lopaschuk GD, McCormack JG. Regulation of substrate metabolism in the diabetic heart. Cardiovasc Res. 1997- 34:25−33.
- Steiner G, Hamsten A, Hosking J, et al. Effect of fenofibrate on progression of coronary-artery disease in type 2 diabetes: the Diabetes Atherosclerosis Intervention Study, a randomised study. Lancet 2001−357:905−10.
- Steiner G. The dyslipoproteinemias of diabetes. Atherosclerosis. 1994- 110: Suppl: P27-P33.
- Stone GW, Ellis SG, Cox DA, et al- TAXUS-IV Investigators. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease.NEJM. 2004−350:221−231.
- Stone GW, Ellis SG, Cox DA, et al- TAXUS-IV Investigators. One-year clinical results with the slowrelease, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trial. Circulation. 2004−109:1942−1947.
- Stout RW. Insulin and atheroma~an update. Lancet. 1987- 1(8541): 1077−1079.
- Stratton L., Adler A., Neil H. et al. Association of glycaemia with macro vascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. Brit. Med. J. 2000−321:405−412.
- Suarez GA, Clark VM, Norell JE et al. Sudden cardiac death in diabetes mellitus: risk factors in the Rochester diabetic neuropathy study. J Neurol Neurosurg Psychiatry 2005−76:240−245.
- Svensson S, Svedjeholm R, Ekroth R. Trauma metabolism of the heart: uptake of substrates and effects of insulin early after cardiac operations. J Thorac Cardiovasc Surg. 1990−99:1063−1073.
- Taegtmeyer H., McNulty P., Young M.E. Adaptation and maladaptation of the heart in diabetes: Part 1. Circulation 2002- 105:1727
- Taskinen M. R. Quantitative and qualitative lipoprotein abnormalities in diabetes mellitus. Diabetes. 1992- 41 (Suppl2): 12−17.
- Tsigos C., Papanicolaou D.A., Defensor R., Mitsiadis C.S., Kyrou I., Chrousos G.P. Dose-effects of recombinant human interleukin-6 on pituitary hormone secretion and energy expenditure. Neuroendocrinology 1997−66:54—62.
- Verma S, Maitland A, Weisel RD, et al. Hyperglycemia exaggerates ischemia-reperfusion-induced cardiomyocyte injury: reversal with endothelin antagonism. J Thorac Cardiovasc Surg. 2002−123:1120−1124.
- Visser L, Zuurbier CJ, Hoek FJ, et al. Glucose, insulin and potassiumapplied as perioperative hyperinsulinaemic normoglycaemic clamp: effects oninflammatory response during coronary artery surgery. Br J Anaesth 2005−95:448 -57.
- Wahab N.N., Cowden E.A., Pearce N.J. et al. Is blood glucose an independent predictor of mortality in acute myocardial infarction in the thrombolytic era? JACC. 2002−40:1748−54
- Werner GS, Bahrmann P, Mutschke O. et al. Determinants of target vessel failure in chronic total coronary occlusions after stent implantation. JACC. 2003−42:219−225.
- West NEJ, Ruygrok PN, Disco CMC, et al. Clinical and angiographic predictors of restenosis after stent deployment in diabetic patients. Circulation 2004−109:867−73.
- Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. DiabetesCare. 2004−27:1047−1053.
- Williams DO, Holubkov R, Yeh W, et al. Percutaneous coronary intervention in the current era compared with 1985−1986: the National Heart, Lung, and Blood Institute Registries. Circulation 2000−102:2945−51.
- Woodfield SL, Lundergan CF, Reiner JS, et al- GUSTO-I Angiographic Investigators. Angiographic findings and outcome in diabeticpatients treated with thrombolytic therapy for acute myocardial infarction: the GUSTO-1 experience. JACC. 1996−28:1661−1669.
- Yamashita K., Okabayashi T., Yokoyama T. et al. The Accuracy of a Continuous Blood Glucose Monitor During Surgery. Anesth Analg 2008- 106:160 163
- Young M.E., McNulty P., Taegtmeyer H. Adaptation and maladaptation of the heart in diabetes: Part II. Circulation 2002- 105:1861